Cotinga Pharmaceuticals Insider ownership
What is the Insider ownership of Cotinga Pharmaceuticals?
The Insider ownership of Cotinga Pharmaceuticals, Inc. is 8.84%
What is the definition of Insider ownership?
Insider Ownership is calculated as the total number of shares owned by insiders (shareholders who own more than 5% of the corporation or an officer or director of the company) divided by the total Shares Outstanding.
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
Insider ownership of companies in the Health Care sector on TSXV compared to Cotinga Pharmaceuticals
What does Cotinga Pharmaceuticals do?
Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.
Companies with insider ownership similar to Cotinga Pharmaceuticals
- First - Indiana has Insider ownership of 8.83%
- NOVA has Insider ownership of 8.83%
- Grocery Outlet Corp has Insider ownership of 8.84%
- Nu has Insider ownership of 8.84%
- American Well Corp has Insider ownership of 8.84%
- California BanCorp has Insider ownership of 8.84%
- Cotinga Pharmaceuticals has Insider ownership of 8.84%
- Oportun Corp has Insider ownership of 8.85%
- Karyopharm Therapeutics Inc has Insider ownership of 8.85%
- Minco Capital has Insider ownership of 8.86%
- Minco Capital has Insider ownership of 8.86%
- Smart Metering Systems Plc has Insider ownership of 8.86%
- Wynn Resorts has Insider ownership of 8.87%